P2X receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

P2X receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on P2X Receptors [48, 141]) have a trimeric topology [124, 139, 188] with two putative TM domains, gating primarily Na+, K+ and Ca2+, exceptionally Cl-. The Nomenclature Subcommittee has recommended that for P2X receptors, structural criteria should be the initial criteria for nomenclature where possible. X-ray crystallography indicates that functional P2X receptors are trimeric and three agonist molecules are required to bind to a single receptor in order to activate it [139, 93, 101, 170]. Native receptors may occur as either homotrimers (e.g. P2X1 in smooth muscle) or heterotrimers (e.g. P2X2:P2X3 in the nodose ganglion [265], P2X1:P2X5 in mouse cortical astrocytes [155], and P2X2:P2X5 in mouse dorsal root ganglion, spinal cord and mid pons [52, 221]. P2X2, P2X4 and P2X7 receptor activation can also lead to influx of large cationic molecules, such as NMDG, Yo-Pro, ethidium or propidium iodide [200]. The hemi-channel pannexin-1 was initially implicated in the action of P2X7 [ 201], but not P2X2, receptors [40], but this interpretation is probably misleading. Convincing evidence now supports the view that the activated P2X7 receptor is immediately permeable to large cationic molecules, but influx proceeds at a much slower pace than that of the small cations Na+, K+, and Ca2+ [64].

[1]  M. Rubio,et al.  Distinct Localization of P2X Receptors at Excitatory Postsynaptic Specializations , 2001, The Journal of Neuroscience.

[2]  A. Ford,et al.  A quantitative analysis of purinoceptor expression in human fetal and adult bladders. , 2001, The Journal of urology.

[3]  S. Nakanishi,et al.  OFF‐cholinergic‐pathway‐selective localization of P2X2 purinoceptors in the mouse retina , 2004, The Journal of comparative neurology.

[4]  D. Donnelly-roberts,et al.  The antihyperalgesic activity of a selective P2X7 receptor antagonist, A-839977, is lost in IL-1αβ knockout mice , 2009, Behavioural Brain Research.

[5]  G. Burnstock,et al.  P 2 X 2 and P 2 X 3 purinoceptors in the rat enteric nervous system , 2004 .

[6]  J. Wiley,et al.  Detection of P 2 X purinergic receptors on human B-lymphocytes , 2016 .

[7]  F. Di Virgilio,et al.  Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. , 1996, Journal of immunology.

[8]  G. Burnstock,et al.  Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors. , 2001, Journal of medicinal chemistry.

[9]  J. Vermylen,et al.  Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotype. , 2003, Blood.

[10]  I. Fearon,et al.  Expression of P2X2 and P2X3 receptor subunits in rat carotid body afferent neurones: role in chemosensory signalling , 2001, The Journal of physiology.

[11]  F. Natt,et al.  Functional Downregulation of P2X3 Receptor Subunit in Rat Sensory Neurons Reveals a Significant Role in Chronic Neuropathic and Inflammatory Pain , 2002, The Journal of Neuroscience.

[12]  F. Di Virgilio,et al.  Design, synthesis and evaluation in an LPS rodent model of neuroinflammation of a novel 18F-labelled PET tracer targeting P2X7 , 2017, EJNMMI Research.

[13]  F. Markwardt,et al.  Antagonism by the suramin analogue NF279 on human P2X(1) and P2X(7) receptors. , 2000, European journal of pharmacology.

[14]  J. Chemin,et al.  P2X2 and P2X5 Subunits Define a New Heteromeric Receptor with P2X7-Like Properties , 2012, The Journal of Neuroscience.

[15]  G Burnstock,et al.  Guinea‐pig sympathetic neurons express varying proportions of two distinct P2X receptors , 2000, The Journal of physiology.

[16]  S. Petrou,et al.  An Ile-568 to Asn Polymorphism Prevents Normal Trafficking and Function of the Human P2X7 Receptor* , 2003, The Journal of Biological Chemistry.

[17]  Geoffrey Burnstock,et al.  Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X 3-deficient mice , 2000, Nature.

[18]  R. North,et al.  An antagonist‐insensitive P2X receptor expressed in epithelia and brain. , 1996, The EMBO journal.

[19]  C. Soeller,et al.  Expression of the P2X2 Receptor Subunit of the ATP-Gated Ion Channel in the Cochlea: Implications for Sound Transduction and Auditory Neurotransmission , 1999, The Journal of Neuroscience.

[20]  G. Burnstock,et al.  P2X7 deficiency attenuates renal injury in experimental glomerulonephritis. , 2009, Journal of the American Society of Nephrology : JASN.

[21]  F. Virgilio,et al.  The Human Cathelicidin LL-37 Modulates the Activities of the P2X7 Receptor in a Structure-dependent Manner* , 2008, Journal of Biological Chemistry.

[22]  A. Nicke,et al.  P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand‐gated ion channels , 1998, The EMBO journal.

[23]  J. Wyatt,et al.  Analgesic profile of intrathecal P2X3 antisense oligonucleotide treatment in chronic inflammatory and neuropathic pain states in rats , 2002, PAIN.

[24]  G Burnstock,et al.  Diinosine pentaphosphate (IP5I) is a potent antagonist at recombinant rat P2X1 receptors , 1999, British journal of pharmacology.

[25]  J. Grosche,et al.  P2X7 Receptor Expression after Ischemia in the Cerebral Cortex of Rats , 2004, Journal of neuropathology and experimental neurology.

[26]  P. Séguéla,et al.  Post-translational regulation of P2X receptor channels: modulation by phospholipids , 2013, Front. Cell. Neurosci..

[27]  R. North,et al.  Immunohistochemical study of the P2X2 and P2X3 receptor subunits in rat and monkey sensory neurons and their central terminals , 1997, Neuropharmacology.

[28]  D. Hume,et al.  ATP Signaling Is Crucial for Communication from Taste Buds to Gustatory Nerves , 2022 .

[29]  R. Evans,et al.  P2X(1) receptor-deficient mice establish the native P2X receptor and a P2Y6-like receptor in arteries. , 2002, Molecular pharmacology.

[30]  G. Tonon,et al.  Novel structurally altered P(2X1) receptor is preferentially activated by adenosine diphosphate in platelets and megakaryocytic cells. , 2001, Blood.

[31]  R. North,et al.  Subunit Arrangement in P2X Receptors , 2003, The Journal of Neuroscience.

[32]  Maho Shibata,et al.  Involvement of P2X7 receptors in the hypoxia-induced death of rat retinal neurons. , 2010, Investigative ophthalmology & visual science.

[33]  K. Jacobson,et al.  Purine and pyrimidine (P2) receptors as drug targets. , 2002, Journal of medicinal chemistry.

[34]  P. Insel,et al.  Autocrine regulation of T‐cell activation by ATP release and P2X7 receptors , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  G. Burnstock,et al.  A P2X purinoceptor expressed by a subset of sensory neurons , 1995, Nature.

[36]  G. Burnstock,et al.  Multiple P2X receptors on guinea‐pig pelvic ganglion neurons exhibit novel pharmacological properties , 2001, British journal of pharmacology.

[37]  S. Antonarakis,et al.  Gene structure and chromosomal localization of the human P2X7 receptor. , 1998, Receptors & channels.

[38]  Sarah A. Middleton,et al.  The purinergic receptor P2X5 regulates inflammasome activity and hyper-multinucleation of murine osteoclasts , 2017, Scientific Reports.

[39]  G. Burnstock,et al.  Changes in expression of P2X1 receptors and connexin 43 in the rat myometrium during pregnancy. , 2007, Fertility and sterility.

[40]  E. Barnard,et al.  Cloning and functional characterisation of the mouse P2X7 receptor , 1998, FEBS letters.

[41]  F. Di Virgilio,et al.  Extracellular adenosine triphosphate and chronic obstructive pulmonary disease. , 2010, American journal of respiratory and critical care medicine.

[42]  J. Cazenave,et al.  Presence of P2X1 Purinoceptors in Human Platelets and Megakaryoblastic Cell Lines , 1997, Thrombosis and Haemostasis.

[43]  G. Burnstock,et al.  P2X7 Receptors Are Expressed during Mouse Nephrogenesis and in Collecting Duct Cysts of the cpk/cpk Mouse , 2002, Nephron Experimental Nephrology.

[44]  S. Govindarajan,et al.  P2X7 Receptors Regulate NKT Cells in Autoimmune Hepatitis1 , 2006, The Journal of Immunology.

[45]  A. Ford,et al.  A quantitative analysis of purinoceptor expression in the bladders of patients with symptomatic outlet obstruction , 2001, BJU international.

[46]  G. Burnstock,et al.  A pyridoxine cyclic phosphate and its 6-azoaryl derivative selectively potentiate and antagonize activation of P2X1 receptors. , 1998, Journal of medicinal chemistry.

[47]  V. Trinkaus-Randall,et al.  Regulation by P2X7: epithelial migration and stromal organization in the cornea. , 2008, Investigative ophthalmology & visual science.

[48]  S. Douglas,et al.  P2X1 stimulation promotes thrombin receptor‐mediated platelet aggregation , 2006, Journal of thrombosis and haemostasis : JTH.

[49]  W. Kussmaul,et al.  Electrophysiological-anatomic correlates of ATP-triggered vagal reflex in the dog. V. Role of purinergic receptors. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[50]  Evgeny M. Zdobnov,et al.  OrthoDB v9.1: cataloging evolutionary and functional annotations for animal, fungal, plant, archaeal, bacterial and viral orthologs , 2016, Nucleic Acids Res..

[51]  J. Gu,et al.  Expression of adenosine triphosphate P2X3 receptors in rat molar pulp and trigeminal ganglia. , 2002, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[52]  G. Burnstock Purine-mediated signalling in pain and visceral perception. , 2001, Trends in pharmacological sciences.

[53]  B. Ryffel,et al.  Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis. , 2010, American journal of respiratory and critical care medicine.

[54]  K. Fitzgerald,et al.  Inflammasome Complexes: Emerging Mechanisms and Effector Functions , 2016, Cell.

[55]  Yu-Qiu Zhang,et al.  Involvement of microglial P2X7 receptors and downstream signaling pathways in long-term potentiation of spinal nociceptive responses , 2010, Brain, Behavior, and Immunity.

[56]  D. Cockayne,et al.  Enhanced thermal avoidance in mice lacking the ATP receptor P2X3 , 2005, Pain.

[57]  F. Di Virgilio,et al.  Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[58]  J. Hoenderop,et al.  P2X6 Knockout Mice Exhibit Normal Electrolyte Homeostasis , 2016, PloS one.

[59]  H. Kita,et al.  ATP drives eosinophil effector responses through P2 purinergic receptors. , 2015, Allergology international : official journal of the Japanese Society of Allergology.

[60]  W. Stühmer,et al.  Antagonistic properties of the suramin analogue NF023 at heterologously expressed P2X receptors , 1999, Neuropharmacology.

[61]  S. M. Sims,et al.  Deletion of the P2X7 nucleotide receptor reveals its regulatory roles in bone formation and resorption. , 2003, Molecular endocrinology.

[62]  G. Burnstock,et al.  Localization of ATP-gated P2X2 and P2X3 receptor immunoreactive nerves in rat taste buds. , 1999, Neuroreport.

[63]  D. Cockayne,et al.  P2X2 knockout mice and P2X2/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATP , 2005, The Journal of physiology.

[64]  M. Voigt,et al.  Gene structure, chromosomal localization, cDNA cloning and expression of the mouse ATP-gated ionotropic receptor P2X5 subunit. , 2001, Gene.

[65]  J. Gillespie,et al.  A Putative Alternatively Spliced Variant of the P2X1 Purinoreceptor in Human Bladder , 2000, Experimental physiology.

[66]  E. Gouaux,et al.  X-ray structures define human P2X3 receptor gating cycle and antagonist action , 2016, Nature.

[67]  S. Feske,et al.  Ion channelopathies of the immune system. , 2018, Current opinion in immunology.

[68]  R. Evans,et al.  A study of P 2 X 1 receptor function in murine megakaryocytes and human platelets reveals synergy with P 2 Y receptors , 2002 .

[69]  G. Dubyak,et al.  Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1β secretion in response to ATP , 2016, Nature Communications.

[70]  A. Nicke,et al.  Heteromeric assembly of P2X subunits , 2013, Front. Cell. Neurosci..

[71]  M. Rubio,et al.  Fe65 Interacts with P2X2 Subunits at Excitatory Synapses and Modulates Receptor Function* , 2006, Journal of Biological Chemistry.

[72]  G. Housley,et al.  Distribution of the P2X2 receptor subunit of the ATP‐gated ion channels in the rat central nervous system , 1999, The Journal of comparative neurology.

[73]  G. Burnstock,et al.  P2X purinoceptors in postmortem human cerebral arteries. , 1998, Journal of cardiovascular pharmacology.

[74]  T. Hedner,et al.  Increase in cardiac P2X1-and P2Y2-receptor mRNA levels in congestive heart failure. , 1999, Life sciences.

[75]  D. Erlinge,et al.  Increased Mitogenic and Decreased Contractile P2 Receptors in Smooth Muscle Cells by Shear Stress in Human Vessels With Intact Endothelium , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[76]  Catherine Vial,et al.  A Role of the Fast ATP-gated P2X1 Cation Channel in Thrombosis of Small Arteries In Vivo , 2003, The Journal of experimental medicine.

[77]  Â. R. Tomé,et al.  Electrophysiological and Immunocytochemical Evidence for P2X Purinergic Receptors in Pancreatic &bgr; Cells , 2008, Pancreas.

[78]  D. Zaykin,et al.  Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity , 2012, Nature Medicine.

[79]  J. Linden,et al.  Purinergic regulation of the immune system , 2016, Nature Reviews Immunology.

[80]  M. Hattori,et al.  Molecular mechanism of ATP binding and ion channel activation in P2X receptors , 2012, Nature.

[81]  D. Cockayne,et al.  Peristalsis is impaired in the small intestine of mice lacking the P2X3 subunit , 2003, The Journal of physiology.

[82]  G. Schuler,et al.  Human monocyte derived dendritic cells express functional P2X and P2Y receptors as well as ecto‐nucleotidases , 1999, FEBS letters.

[83]  K. Jacobson,et al.  Development of selective agonists and antagonists of P2Y receptors , 2008, Purinergic Signalling.

[84]  A. Surprenant,et al.  Pannexin-1 Couples to Maitotoxin- and Nigericin-induced Interleukin-1β Release through a Dye Uptake-independent Pathway* , 2007, Journal of Biological Chemistry.

[85]  A Townsend-Nicholson,et al.  Localization of P2X1 purinoceptors by autoradiography and immunohistochemistry in rat kidneys. , 1998, American journal of physiology. Renal physiology.

[86]  P. Séguéla,et al.  Modulation of heteromeric P2X1/5 receptors by phosphoinositides in astrocytes depends on the P2X1 subunit , 2010, Journal of neurochemistry.

[87]  V. Lagente,et al.  Purinergic receptors: new targets for the treatment of gout and fibrosis , 2017, Fundamental & clinical pharmacology.

[88]  G. Burnstock,et al.  The purinergic component of human vas deferens contraction. , 2006, Fertility and sterility.

[89]  D. Donnelly-roberts,et al.  A-740003 [N-(1-{[(Cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a Novel and Selective P2X7 Receptor Antagonist, Dose-Dependently Reduces Neuropathic Pain in the Rat , 2006, Journal of Pharmacology and Experimental Therapeutics.

[90]  F. Di Virgilio,et al.  P2X7 receptor signaling in the pathogenesis of smoke-induced lung inflammation and emphysema. , 2011, American journal of respiratory cell and molecular biology.

[91]  W. Wier,et al.  Purinergic and Adrenergic Ca2+ Transients during Neurogenic Contractions of Rat Mesenteric Small Arteries , 2003, The Journal of physiology.

[92]  B. Sperlágh,et al.  P2X7 receptor-mRNA and -protein in the mouse retina; changes during retinal degeneration in BALBCrds mice , 2005, Neurochemistry International.

[93]  R. Murrell-Lagnado,et al.  The trafficking and targeting of P2X receptors , 2013, Front. Cell. Neurosci..

[94]  A Townsend-Nicholson,et al.  Molecular cloning, functional characterization and possible cooperativity between the murine P2X4 and P2X4a receptors. , 1999, Brain research. Molecular brain research.

[95]  A. Conigrave,et al.  Chelerythrine and other benzophenanthridine alkaloids block the human P2X7 receptor , 2004, British journal of pharmacology.

[96]  R. North,et al.  Cloning OF P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[97]  M. Miras-Portugal,et al.  Presence of diverse functional P2X receptors in rat cerebellar synaptic terminals. , 2005, Biochemical pharmacology.

[98]  R. North,et al.  A new class of ligand-gated ion channel defined by P2X receptor for extracellular ATP , 1994, Nature.

[99]  B. Khakh,et al.  ATP Modulation of Excitatory Synapses onto Interneurons , 2003, The Journal of Neuroscience.

[100]  R. Hodges,et al.  Characterization of P2X7 purinergic receptors and their function in rat lacrimal gland. , 2009, Investigative Ophthalmology and Visual Science.

[101]  J. Furness,et al.  The distribution of P2X3 purine receptor subunits in the guinea pig enteric nervous system , 2002, Autonomic Neuroscience.

[102]  P. Bonaventure,et al.  Neuropharmacology and analgesia A novel radioligand for the ATP-gated ion channel P 2 X 7 : [ 3 H ] JNJ-54232334 , 2015 .

[103]  Expression of P2X7 receptor increases in vivo tumor growth. , 2012, Cancer research.

[104]  F. Di Virgilio,et al.  The P2X7 Receptor in Infection and Inflammation , 2017, Immunity.

[105]  B S Khakh,et al.  Allosteric Control of Gating and Kinetics at P2X4Receptor Channels , 1999, The Journal of Neuroscience.

[106]  Edward W Inscho,et al.  Physiological role for P2X1 receptors in renal microvascular autoregulatory behavior. , 2003, The Journal of clinical investigation.

[107]  B. Khakh,et al.  Patch–clamp coordinated spectroscopy shows P2X2 receptor permeability dynamics require cytosolic domain rearrangements but not Panx-1 channels , 2008, Proceedings of the National Academy of Sciences.

[108]  N. Chauret,et al.  BLU-5937: A selective P2X3 antagonist with potent anti-tussive effect and no taste alteration. , 2019, Pulmonary pharmacology & therapeutics.

[109]  F. Di Virgilio,et al.  The Antibiotic Polymyxin B Modulates P2X7 Receptor Function1 , 2004, The Journal of Immunology.

[110]  G. Burnstock,et al.  Purinergic signalling and immune cells , 2014, Purinergic Signalling.

[111]  J. Vermylen,et al.  A Natural Dominant Negative P2X1 Receptor Due to Deletion of a Single Amino Acid Residue* , 2000, The Journal of Biological Chemistry.

[112]  C. Lecut,et al.  P2X1 expressed on polymorphonuclear neutrophils and platelets is required for thrombosis in mice. , 2014, Blood.

[113]  M. Seman,et al.  Cutting Edge: A Natural P451L Mutation in the Cytoplasmic Domain Impairs the Function of the Mouse P2X7 Receptor1 , 2002, The Journal of Immunology.

[114]  G. Burnstock,et al.  Localization of ATP-gated P2X receptor immunoreactivity in rat sensory and sympathetic ganglia , 1998, Neuroscience Letters.

[115]  A Pelleg,et al.  Mechanism of action of ATP on canine pulmonary vagal C fibre nerve terminals. , 1996, The Journal of physiology.

[116]  F. Di Virgilio P2RX7: A receptor with a split personality in inflammation and cancer , 2016, Molecular & cellular oncology.

[117]  G. Burnstock,et al.  Differential expression of P2X receptors on neurons from different parasympathetic ganglia , 2005, Neuropharmacology.

[118]  J. Wiley,et al.  Extracellular ATP Increases Cation Fluxes in Human Erythrocytes by Activation of the P2X7 Receptor* , 2004, Journal of Biological Chemistry.

[119]  P. Barnes,et al.  Extracellular Adenosine 5'-Triphosphate in Obstructive Airway Diseases. , 2016, Chest.

[120]  J. Brown,et al.  Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors , 2000, Nature.

[121]  K. M. Spyer,et al.  Pivotal Role of Nucleotide P2X2 Receptor Subunit of the ATP-Gated Ion Channel Mediating Ventilatory Responses to Hypoxia , 2003, The Journal of Neuroscience.

[122]  J. Gever,et al.  AF‐353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist , 2010, British journal of pharmacology.

[123]  R. Gómez-Villafuertes,et al.  Axodendritic fibres of mouse cerebellar granule neurons exhibit a diversity of functional P2X receptors , 2009, Neurochemistry International.

[124]  E. Kawashima,et al.  Tissue distribution of the P2X7 receptor , 1997, Neuropharmacology.

[125]  H. de la Salle,et al.  The P2X1 Receptor Is Required for Neutrophil Extravasation during Lipopolysaccharide-Induced Lethal Endotoxemia in Mice , 2015, The Journal of Immunology.

[126]  J. Furness,et al.  The distribution of purine P2X(2) receptors in the guinea-pig enteric nervous system. , 2002, Histochemistry and cell biology.

[127]  W. Stühmer,et al.  Characterization of recombinant human P2X4 receptor reveals pharmacological differences to the rat homologue. , 1997, Molecular pharmacology.

[128]  H. Tozaki-Saitoh,et al.  A novel P2X4 receptor-selective antagonist produces anti-allodynic effect in a mouse model of herpetic pain , 2016, Scientific Reports.

[129]  R. North,et al.  P2X1 and P2X5 Subunits Form the Functional P2X Receptor in Mouse Cortical Astrocytes , 2008, The Journal of Neuroscience.

[130]  M. Ikeda,et al.  Therapeutic effects of the putative P2X3/P2X2/3 antagonist A-317491 on cyclophosphamide-induced cystitis in rats , 2008, Naunyn-Schmiedeberg's Archives of Pharmacology.

[131]  A. Colomar,et al.  ATP stimulation of P2X7 receptors activates three different ionic conductances on cultured mouse Schwann cells , 2001, The European journal of neuroscience.

[132]  D. Ferrari,et al.  ATP-mediated cytotoxicity in microglial cells , 1997, Neuropharmacology.

[133]  M. Kassack,et al.  Structure-activity relationships of analogues of NF449 confirm NF449 as the most potent and selective known P2X1 receptor antagonist. , 2004, European journal of medicinal chemistry.

[134]  T. Kawate,et al.  Structural basis for subtype-specific inhibition of the P2X7 receptor , 2016, eLife.

[135]  W. Stühmer,et al.  Molecular characterization and pharmacological properties of the human P2X3 purinoceptor. , 1997, Brain research. Molecular brain research.

[136]  Robert Elde,et al.  Distinct ATP receptors on pain-sensing and stretch-sensing neurons , 1997, Nature.

[137]  S. Fleischer,et al.  Calcium signalling through nucleotide receptor P2X1 in rat portal vein myocytes , 2001, The Journal of physiology.

[138]  Graham L. Collingridge,et al.  A nomenclature for ligand-gated ion channels , 2009, Neuropharmacology.

[139]  J. Gever,et al.  Antagonism of ATP responses at P2X receptor subtypes by the pH indicator dye, Phenol red , 2005, British journal of pharmacology.

[140]  M. Heath,et al.  Identification of a P2X1 purinoceptor expressed on human platelets. , 1998, Biochemical and biophysical research communications.

[141]  K. Limesand,et al.  P2X7 receptor antagonism prevents IL-1β release from salivary epithelial cells and reduces inflammation in a mouse model of autoimmune exocrinopathy , 2017, The Journal of Biological Chemistry.

[142]  M. Braddock,et al.  Characterization of a selective and potent antagonist of human P2X7 receptors, AZ11645373 , 2006, British journal of pharmacology.

[143]  J. Yamazaki,et al.  Presence and possible role of the spliced isoform of the P2X1 receptor in rat vascular smooth muscle cells , 2000, Pflügers Archiv.

[144]  G. Housley,et al.  Immunohistochemical localization of adenosine 5`‐triphosphate‐gated ion channel P2X2 receptor subunits in adult and developing rat cochlea , 2000, The Journal of comparative neurology.

[145]  G. Burnstock,et al.  Purinergic receptors are part of a functional signaling system for proliferation and differentiation of human epidermal keratinocytes. , 2003, The Journal of investigative dermatology.

[146]  D. Donnelly-roberts,et al.  Discovery of P2X7 receptor‐selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states , 2007, British journal of pharmacology.

[147]  P. Bonaventure,et al.  Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ‐47965567 , 2013, British journal of pharmacology.

[148]  Emma J. Kidd,et al.  Warm-coding deficits and aberrant inflammatory pain in mice lacking P2X 3 receptors , 2000, Nature.

[149]  A. Gartland,et al.  Blockade of the Pore-Forming P2X7 Receptor Inhibits Formation of Multinucleated Human Osteoclasts In Vitro , 2003, Calcified Tissue International.

[150]  S. Greenfeder,et al.  Identification and characterization of splice variants of the human P2X7 ATP channel. , 2005, Biochemical and biophysical research communications.

[151]  F. Di Virgilio,et al.  Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells , 2007, Nature Medicine.

[152]  F. Symon,et al.  Impaired P2X1 Receptor–Mediated Adhesion in Eosinophils from Asthmatic Patients , 2016, The Journal of Immunology.

[153]  F. Di Virgilio,et al.  A His-155 to Tyr Polymorphism Confers Gain-of-Function to the Human P2X7 Receptor of Human Leukemic Lymphocytes1 , 2005, The Journal of Immunology.

[154]  G. Housley,et al.  ATP-gated ion channels assembled from P2X2 receptor subunits in the mouse cochlea , 2002, Neuroreport.

[155]  G. Burnstock,et al.  P2X and P2Y purinoceptor expression in pancreas from streptozotocin-diabetic rats , 2003, Molecular and Cellular Endocrinology.

[156]  S. Petrou,et al.  An Arg307 to Gln Polymorphism within the ATP-binding Site Causes Loss of Function of the Human P2X7 Receptor* , 2004, Journal of Biological Chemistry.

[157]  D. Kumararatne,et al.  ATP-mediated killing of intracellular mycobacteria by macrophages is a P2X(7)-dependent process inducing bacterial death by phagosome-lysosome fusion. , 2002, Journal of immunology.

[158]  E A Barnard,et al.  Localization and functional expression of splice variants of the P2X2 receptor. , 1997, Molecular pharmacology.

[159]  J. Deuchars,et al.  An evaluation of antibody detection of the P2X1 receptor subunit in the CNS of wild type and P2X1-knockout mice , 2006, Neuroscience Letters.

[160]  S. Antonarakis,et al.  Characterization and chromosomal localization of a human P2X receptor from the urinary bladder. , 1995, Receptors & channels.

[161]  R. Evans,et al.  P2X Receptor Immunoreactivity in Different Arteries from the Femoral, Pulmonary, Cerebral, Coronary and Renal Circulations , 2001, Journal of Vascular Research.

[162]  R. North,et al.  Pharmacological and biophysical properties of the human P2X5 receptor. , 2003, Molecular pharmacology.

[163]  R Elde,et al.  Differential distribution of two ATP-gated channels (P2X receptors) determined by immunocytochemistry. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[164]  C. Gargett,et al.  The isoquinoline derivative KN‐62 a potent antagonist of the P2Z‐receptor of human lymphocytes , 1997, British journal of pharmacology.

[165]  Y. Lin,et al.  Mediator mechanisms involved in TRPV1 and P2X receptor-mediated, ROS-evoked bradypneic reflex in anesthetized rats. , 2006, Journal of applied physiology.

[166]  Geoffrey Burnstock,et al.  A P2X purinoceptor cDNA conferring a novel pharmacological profile , 1995, FEBS letters.

[167]  Eric Gouaux,et al.  Pore architecture and ion sites in acid sensing ion channels and P2X receptors , 2009, Nature.

[168]  R. North,et al.  Reanalysis of P2X7 Receptor Expression in Rodent Brain , 2004, The Journal of Neuroscience.

[169]  M. Schaefer,et al.  Clemastine Potentiates the Human P2X7 Receptor by Sensitizing It to Lower ATP Concentrations* , 2011, The Journal of Biological Chemistry.

[170]  C. Brosnan,et al.  The cytokine IL‐1β transiently enhances P2X7 receptor expression and function in human astrocytes , 2005, Glia.

[171]  P. Séguéla,et al.  A novel neuronal P2x ATP receptor ion channel with widespread distribution in the brain , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[172]  P. Anand,et al.  Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain , 2005, Pain.

[173]  A. Farce,et al.  Pyroglutamide-Based P2X7 Receptor Antagonists Targeting Inflammatory Bowel Disease. , 2020, Journal of medicinal chemistry.

[174]  F. Di Virgilio,et al.  The P2X7 receptor sustains the growth of human neuroblastoma cells through a substance P-dependent mechanism. , 2006, Cancer research.

[175]  J. Simon,et al.  Species and response dependent differences in the effects of MAPK inhibitors on P2X7 receptor function , 2006, British journal of pharmacology.

[176]  K. Kohler,et al.  Expression of the P2X7-receptor subunit in neurons of the rat retina. , 1998, Brain research. Molecular brain research.

[177]  B. Robertson,et al.  P2X7 Mediates Superoxide Production in Primary Microglia and Is Up-regulated in a Transgenic Mouse Model of Alzheimer's Disease* , 2003, The Journal of Biological Chemistry.

[178]  E. Gouaux,et al.  Crystal structure of the ATP-gated P2X4 ion channel in the closed state , 2009, Nature.

[179]  F. Di Virgilio,et al.  Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor. , 1993, The Journal of biological chemistry.

[180]  R. Doctor,et al.  Characterization of ionotrophic purinergic receptors in hepatocytes , 2007, Hepatology.

[181]  Michael F. Jarvis,et al.  ISSUE IN MEMORY OF AVRAM GOLDSTEIN P 2 X Receptors as Drug Targets , 2013 .

[182]  R. North,et al.  Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons , 1995, Nature.

[183]  G. Burnstock,et al.  P2X receptor immunoreactivity in the rat cochlea, vestibular ganglion and cochlear nucleus , 1999, Hearing Research.

[184]  J. Gever,et al.  Pharmacology of P2X channels , 2006, Pflügers Archiv.

[185]  N. Alexis,et al.  Extracellular purines are biomarkers of neutrophilic airway inflammation , 2008, European Respiratory Journal.

[186]  S. Fuller,et al.  A 5′ intronic splice site polymorphism leads to a null allele of the P2X7 gene in 1–2% of the Caucasian population , 2005, FEBS letters.

[187]  R. Evans,et al.  P 2 X 1 Receptor-Deficient Mice Establish the Native P 2 X Receptor and a P 2 Y 6-Like Receptor in Arteries , 2002 .

[188]  T. van Biesen,et al.  Molecular and functional characterization of human P2X(2) receptors. , 1999, Molecular pharmacology.

[189]  Annette Nicke,et al.  Molecular and functional properties of P2X receptors—recent progress and persisting challenges , 2012, Purinergic Signalling.

[190]  P. Anand,et al.  COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord , 2006, BMC neurology.

[191]  D. Walter,et al.  Negative and positive allosteric modulators of the P2X(7) receptor. , 2008, British journal of pharmacology.

[192]  R. North,et al.  Trinitrophenyl-Substituted Nucleotides Are Potent Antagonists Selective for P 2 X 1 , P 2 X 3 , and Heteromeric P 2 X 2 / 3 Receptors , 1998 .

[193]  A. Michel,et al.  Decavanadate, a P2X receptor antagonist, and its use to study ligand interactions with P2X7 receptors. , 2006, European journal of pharmacology.

[194]  S. McMahon,et al.  The expression of P2X3 purinoreceptors in sensory neurons: effects of axotomy and glial-derived neurotrophic factor. , 1998, Molecular and cellular neurosciences.

[195]  R. North,et al.  Brilliant blue G selectively blocks ATP-gated rat P2X(7) receptors. , 2000, Molecular pharmacology.

[196]  K. Jacobson,et al.  Medicinal chemistry of adenosine, P2Y and P2X receptors , 2016, Neuropharmacology.

[197]  G. Burnstock,et al.  Expression of P2X and P2Y receptors in the intramural parasympathetic ganglia of the cat urinary bladder. , 2006, American journal of physiology. Renal physiology.

[198]  Beverly H. Koller,et al.  Altered Cytokine Production in Mice Lacking P2X7Receptors* , 2001, The Journal of Biological Chemistry.

[199]  C. Takiya,et al.  The role of purinergic P2X7 receptors in the inflammation and fibrosis of unilateral ureteral obstruction in mice. , 2006, Kidney international.

[200]  C. Yoshioka,et al.  Full-Length P2X7 Structures Reveal How Palmitoylation Prevents Channel Desensitization , 2019, Cell.

[201]  S. Senger,et al.  Discovery and structure-activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptor. , 2010, Bioorganic & medicinal chemistry letters.

[202]  D. Donnelly-roberts,et al.  Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors , 2009, British journal of pharmacology.

[203]  P. Séguéla,et al.  Primary structure and expression of a naturally truncated human P2X ATP receptor subunit from brain and immune system , 1997, FEBS letters.

[204]  C. Gabel,et al.  Absence of the P2X7 Receptor Alters Leukocyte Function and Attenuates an Inflammatory Response , 2002, The Journal of Immunology.

[205]  Huafeng Zhang,et al.  Endotoxin-induced autocrine ATP signaling inhibits neutrophil chemotaxis through enhancing myosin light chain phosphorylation , 2017, Proceedings of the National Academy of Sciences.

[206]  D. Donnelly-roberts,et al.  Mitogen-Activated Protein Kinase and Caspase Signaling Pathways Are Required for P2X7 Receptor (P2X7R)-Induced Pore Formation in Human THP-1 Cells , 2004, Journal of Pharmacology and Experimental Therapeutics.

[207]  A. Nicke,et al.  A Functional P2X7 Splice Variant with an Alternative Transmembrane Domain 1 Escapes Gene Inactivation in P2X7 Knock-out Mice* , 2009, The Journal of Biological Chemistry.

[208]  R. Cunha,et al.  Dual Presynaptic Control by ATP of Glutamate Release via Facilitatory P2X1, P2X2/3, and P2X3 and Inhibitory P2Y1, P2Y2, and/or P2Y4 Receptors in the Rat Hippocampus , 2005, The Journal of Neuroscience.

[209]  S. Seino,et al.  Cloning and pharmacological characterization of a fourth P2X receptor subtype widely expressed in brain and peripheral tissues including various endocrine tissues. , 1996, Biochemical and biophysical research communications.

[210]  S. M. Sims,et al.  Activity-dependent Development of P2X7 Current and Ca2+ Entry in Rabbit Osteoclasts* , 2001, The Journal of Biological Chemistry.

[211]  F. Di Virgilio,et al.  The P2X7 receptor: A main player in inflammation , 2017, Biochemical pharmacology.

[212]  Q. Zheng Radioligands targeting purinergic P2X7 receptor. , 2020, Bioorganic & medicinal chemistry letters.

[213]  F. Di Virgilio,et al.  The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role. , 1995, The Journal of clinical investigation.

[214]  I. Chessell,et al.  Blockade of human P2X7 receptor function with a monoclonal antibody. , 1998, Blood.

[215]  Identification of regions of the P2X7 receptor that contribute to human and rat species differences in antagonist effects , 2008, British journal of pharmacology.

[216]  R. Evans,et al.  Smooth muscle does not have a common P2x receptor phenotype: expression, ontogeny and function of P2x1 receptors in mouse ileum, bladder and reproductive systems , 2001, Autonomic Neuroscience.

[217]  A. Woolf,et al.  The P2X7 ATP receptor modulates renal cyst development in vitro. , 2004, Biochemical and biophysical research communications.

[218]  M. Schaefer,et al.  Positive allosteric modulation by ivermectin of human but not murine P2X7 receptors , 2012, British journal of pharmacology.

[219]  F. Di Virgilio,et al.  A role for P2X7 in microglial proliferation , 2006, Journal of neurochemistry.

[220]  I. Chessell,et al.  Functional regulation of P2X6 receptors by N-linked glycosylation: identification of a novel alpha beta-methylene ATP-sensitive phenotype. , 2004, Molecular pharmacology.

[221]  J. Kamei,et al.  Involvement of ionotropic purinergic receptors in the histamine-induced enhancement of the cough reflex sensitivity in guinea pigs. , 2006, European journal of pharmacology.

[222]  G. Schmalzing,et al.  The suramin analogue NF279 is a novel and potent antagonist selective for the P2X1 receptor , 2000, Neuropharmacology.

[223]  J. Pintor,et al.  Co-localisation of functional nicotinic and ionotropic nucleotide receptors in isolated cholinergic synaptic terminals , 2002, Neuropharmacology.

[224]  R. Marée,et al.  P2X1 Ion Channels Promote Neutrophil Chemotaxis through Rho Kinase Activation , 2009 .

[225]  C. D. dos Remedios,et al.  Increase in expression of P2X1 receptors in the atria of patients suffering from dilated cardiomyopathy , 1999, Electrophoresis.

[226]  F. Di Virgilio,et al.  Extracellular purines, purinergic receptors and tumor growth , 2016, Oncogene.

[227]  F. Di Virgilio Novel data point to a broader mechanism of action of oxidized ATP: the P2X7 receptor is not the only target , 2003, British journal of pharmacology.

[228]  G. Burnstock,et al.  P2X2 and P2X3 receptor expression in the gallbladder of the guinea pig , 2004, Autonomic Neuroscience.

[229]  T. Pawełczyk,et al.  Purinergic signaling in B cells. , 2018, Acta biochimica Polonica.

[230]  B S Khakh,et al.  International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. , 2001, Pharmacological reviews.

[231]  M. Decker,et al.  Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: Relevance for neuropsychiatric disorders , 2009, Behavioural Brain Research.

[232]  M. Fox,et al.  Structure and chromosomal mapping of the mouse P2X3 gene. , 1997, Gene.

[233]  R. Santer,et al.  Age-associated changes in distribution of the P2X2 receptor in the major pelvic ganglion of the male rat. , 2006, Neuroscience Letters.

[234]  N. Copeland,et al.  Structure and chromosome location of the mouse P2X1 purinoceptor gene (P2rx1) , 2001, Cytogenetic and Genome Research.

[235]  C. Karschin,et al.  P 2 X 4 : An ATP-activated ionotropic receptor cloned from rat brain ( purinergic receptor ) , 2022 .

[236]  Yi Dai,et al.  Differential expression patterns of mRNAs for P2X receptor subunits in neurochemically characterized dorsal root ganglion neurons in the rat , 2005, The Journal of comparative neurology.

[237]  F. Di Virgilio,et al.  Increased Proliferation Rate of Lymphoid Cells Transfected with the P2X7 ATP Receptor* , 1999, The Journal of Biological Chemistry.

[238]  Gary Layton,et al.  P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study , 2015, The Lancet.

[239]  G. Burnstock,et al.  Ultrastructural localization of P2X3receptors in rat sensory neurons , 1998, Neuroreport.

[240]  K. Wareham,et al.  Functional evidence for the expression of P2X1, P2X4 and P2X7 receptors in human lung mast cells , 2009, British journal of pharmacology.

[241]  T. Tokino,et al.  Cloning and characterization of the murine P2XM receptor gene , 1998, Journal of Human Genetics.

[242]  D. Davidson,et al.  The role of the purinergic P2X7 receptor in inflammation , 2007, Journal of Inflammation.

[243]  S. M. Sims,et al.  Expression, signaling, and function of P2X7 receptors in bone , 2009, Purinergic Signalling.

[244]  S. Petrou,et al.  A Glu-496 to Ala Polymorphism Leads to Loss of Function of the Human P2X7 Receptor* , 2001, The Journal of Biological Chemistry.

[245]  K. K. Rau,et al.  Co-expression of P2X receptor subunits on rat nodose neurons that bind the isolectin GS-I-B4 , 2001, Neuroreport.

[246]  J. Bornstein,et al.  ATP as a Putative Sensory Mediator: Activation of Intrinsic Sensory Neurons of the Myenteric Plexus via P2X Receptors , 2002, The Journal of Neuroscience.

[247]  F. Di Virgilio,et al.  Human primary fibroblasts in vitro express a purinergic P2X7 receptor coupled to ion fluxes, microvesicle formation and IL-6 release. , 1999, Journal of cell science.

[248]  A. Kalgutkar,et al.  Optimization of the physicochemical and pharmacokinetic attributes in a 6-azauracil series of P2X7 receptor antagonists leading to the discovery of the clinical candidate CE-224,535. , 2011, Bioorganic & medicinal chemistry letters.

[249]  G. Hutchins,et al.  Characterization of 11C-GSK1482160 for Targeting the P2X7 Receptor as a Biomarker for Neuroinflammation , 2017, The Journal of Nuclear Medicine.

[250]  Geoffrey Burnstock,et al.  Coexpression of mRNAs for P2X1, P2X2 and P2X4 Receptors in Rat Vascular Smooth Muscle: An in situ Hybridization and RT-PCR Study , 1998, Journal of Vascular Research.

[251]  G. Burnstock,et al.  Neurochemical identification of enteric neurons expressing P2X3 receptors in the guinea-pig ileum , 2002, Histochemistry and Cell Biology.

[252]  D. Julius,et al.  New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor , 1994, Nature.

[253]  J. Gever,et al.  Purinoceptors as therapeutic targets for lower urinary tract dysfunction , 2006, British journal of pharmacology.

[254]  A. IJzerman,et al.  Pharmacological analysis of ecto‐ATPase inhibition: evidence for combined enzyme inhibition and receptor antagonism in P2X‐purinoceptor ligands , 1994, British journal of pharmacology.

[255]  G. Burnstock,et al.  P2X1 receptors are closely associated with connexin 43 in human ventricular myocardium. , 2005, International journal of cardiology.

[256]  D. Cockayne,et al.  P2X2 subunits contribute to fast synaptic excitation in myenteric neurons of the mouse small intestine , 2003, The Journal of physiology.

[257]  F. Di Virgilio,et al.  The Elusive P2X7 Macropore. , 2018, Trends in cell biology.

[258]  G. Burnstock,et al.  Glomerular expression of the ATP-sensitive P2X receptor in diabetic and hypertensive rat models. , 2004, Kidney international.

[259]  G. Burnstock,et al.  Development of nerves expressing P2X3 receptors in the myenteric plexus of rat stomach , 2004, Histochemistry and Cell Biology.

[260]  T. Brennan,et al.  A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[261]  F. Di Virgilio,et al.  P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. , 2002, Blood.

[262]  J. Kamei,et al.  Involvement of P2X receptor subtypes in ATP-induced enhancement of the cough reflex sensitivity. , 2005, European journal of pharmacology.

[263]  G. Dubyak,et al.  Oxidized ATP (oATP) attenuates proinflammatory signaling via P2 receptor‐independent mechanisms , 2003, British journal of pharmacology.

[264]  Min Zhang,et al.  Co‐release of ATP and ACh mediates hypoxic signalling at rat carotid body chemoreceptors , 2000, The Journal of physiology.

[265]  F. Di Virgilio,et al.  Purines, purinergic receptors, and cancer. , 2012, Cancer research.